Annual report pursuant to Section 13 and 15(d)

STOCK COMPENSATION PLANS (Details)

v2.4.0.6
STOCK COMPENSATION PLANS (Details) (USD $)
In Millions, except Share data, unless otherwise specified
12 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2011
2010-2012 Performance Period
Dec. 31, 2011
2011-2013 Performace Period
Dec. 31, 2011
CCE's North American business
Dec. 31, 2010
CCE's North American business
Dec. 31, 2010
CCE's North American business
Performance Period 2008-2010, 2009 and 2010
Dec. 31, 2011
CCE's North American business
Performance Period 2008-2010 and 2010
Dec. 31, 2010
CCE's North American business
Performance Period 2008-2010 and 2010
Dec. 31, 2010
CCE's North American business
2009 Performance Period
Dec. 31, 2010
CCE's North American business
2009 Performance Period
Dec. 31, 2011
CCE's North American business
CCE 2007 Performance Grants
Dec. 31, 2011
1999 Option Plan
Dec. 31, 2011
2002 Option Plan
Dec. 31, 2011
2008 Option Plan
Dec. 31, 2011
Stock options granted in December 2003 and thereafter
Dec. 31, 2011
Stock options granted from 1999 through July 2003
Dec. 31, 2011
Performance share units
Dec. 31, 2011
Performance share units
2008-2010 Performance Period
Dec. 31, 2011
Restricted stock
Dec. 31, 2011
1989 Restricted Stock Award Plan
Dec. 31, 2011
1983 Restricted Stock Award Plan
Dec. 31, 2011
Time-Based Restricted Stock Unit Awards
Dec. 31, 2011
Time-Based Restricted Stock Unit Awards
CCE's North American business
Dec. 31, 2011
Performance-based Restricted Stock Unit Awards
STOCK COMPENSATION PLANS [Abstract]                                                    
Total stock-based compensation expense $ 354 $ 380 $ 241                                              
Total income tax benefit recognized in consolidated statements of income for share-based compensation arrangements 99 110 68                                              
Total unrecognized compensation cost related to nonvested share-based compensation arrangements granted 516                                                  
Weighted-average period over which the total unrecognized compensation cost is expected to be recognized (in years) 1.8                                                  
Stock-based compensation awards                                                    
Share based compensation arrangement by share based payment award equity instruments other than options outstanding and nonvested                                         154,500          
Vesting period of stock-based awards (in years)           3                                        
Weighted-average assumptions used in the Black Scholes Merton option pricing model                                                    
Fair value of options at grant date (in dollars per share) $ 9.28 $ 9.39 $ 6.38                                              
Dividend yield (as a percent) 2.70% 2.90% 3.40%                                              
Expected volatility (as a percent) 19.00% 20.00% 20.00%                                              
Risk-free interest rate (as a percent) 2.30% 3.00% 2.80%                                              
Expected term of the option (in years) 5 6 6                                              
Share-based compensation disclosure                                                    
Common stock was approved to be issued or transferred through the grant of stock options (in shares) 90,000,000                         120,000,000 120,000,000 140,000,000           40,000,000 24,000,000      
Outstanding on January 1, 2011 (in shares) 171,000,000                                                  
Granted (in shares) 26,000,000                                                  
Exercised (in shares) (32,000,000) (37,000,000) (15,000,000)                                              
Forfeited/expired (in shares) (3,000,000)                                                  
Outstanding on December 31, 2011 (in shares) 162,000,000 171,000,000                                                
Expected to vest at December 31, 2011 (in shares) 160,000,000                                                  
Exercisable on December 31, 2011 (in shares) 106,000,000         3,000,000                                        
Outstanding on January 1, 2011, Weighted-Average Exercise Price (in dollars per share) $ 48.77                                                  
Granted, Weighted-Average Exercise Price (in dollars per share) $ 64.03                                                  
Exercised, Weighted-Average Exercise Price (in dollars per share) $ 47.96                                                  
Forfeited/expired, Weighted-Average Exercise Price (in dollars per share) $ 53.77                                                  
Outstanding on December 31. 2011, Weighted-Average Exercise Price (in dollars per share) $ 51.23 $ 48.77                                                
Expected to vest at December 31, 2011, Weighted-Average Exercise Price (in dollars per share) $ 51.13                                                  
Exercisable on December 31, 2011, Weighted-Average Exercise Price (in dollars per share) $ 48.65         $ 36.98                                        
Outstanding on December 31, 2011, Weighted-Average Remaining Contractual Life (in years) 5.93                                                  
Expected to vest at December 31, 2011, Weighted-Average Remaining Contractual Life (in years) 5.90                                                  
Exercisable on December 31, 2011, Weighted-Average Remaining Contractual Life (in years) 4.76                                                  
Outstanding on December 31, 2011, Aggregate Intrinsic Value (in dollars) 3,028                                                  
Expected to vest at December 31, 2011, Aggregate Intrinsic Value (in dollars) 3,009                                                  
Exercisable on December 31, 2011, Aggregate Intrinsic Value (in dollars) 2,266                                                  
Expiration period of stock-based awards (in years)           10                     10 15                
Total intrinsic value of options exercised during the year 631 524 146                                              
Number of Shares Available for Grant           14,000,000                             19,000,000          
Summary disclosures                                                    
Outstanding on January 1, 2011 (in shares)       2,716,000 2,967,000                           5,254,000         367,000 309,000 130,000
Conversion to Restricted Stock Units                                     (2,311,000)              
Paid in cash equivalent (in shares) (9,731) (13,825) (20,958)                               (10,000)              
Canceled/forfeited (in shares)                                     (304,000)   (17,000)          
Outstanding on December 31, 2011 (in shares)       2,716,000 2,967,000                           5,683,000         367,000 309,000 130,000
Outstanding on January 1, 2011, Weighted-Average Grant-Date Fair Value (in dollars per share)                                     $ 51.60   $ 43.29          
Granted, Weighted-Average Grant-Date Fair Value (in dollars per share)               $ 59.12                     $ 51.16   $ 53.08          
Convertion to restricted Stock in Period Weighted Average Grant Date Fair Value                                     $ 53.08              
Paid in cash equivalent, Weighted-Average Grant-Date Fair Value (in dollars per share)                                     $ 53.13              
Canceled/forfeited, Weighted-Average Grant-Date Fair Value (in dollars per share)                                     $ 50.56   $ 43.71          
Outstanding on December 31, 2011, Weighted-Average Grant-Date Fair Value (in dollars per share)                                     $ 50.81   $ 53.05          
Novested at target on January 1, 2011 (in shares)                                         797,000          
Vested and released (in shares) (1,023,597)                                       (1,024,000)          
Restricted shares units vested and released (in shares) (1,042,456) (925,233) (1,269,604)                                              
Nonvested at target on December 31, 2011 (in shares)                                         2,067,000          
Vested and released, Weighted-Average Grant-Date Fair Value (in dollars per share)                                         $ 45.72          
Number of shares issued due to modification in the performance awards                 1,500,000   1,400,000                              
Actual payout (in percent)                     200.00% 200.00%                            
Intrinsic value of shares issued due to modification in the performance awards                   98   91                            
Outstanding performance share units at the Threshold Award Level (in shares) 2,800,000           300,000                                      
Outstanding performance share units at the Maximum Award Level (in shares) 8,500,000                                                  
Performance share awards paid in cash equivalent, value 0.7 0.7 1.1                                              
Performance period for determining the number of shares earned by an employee, low end of the range (in years)                         1                          
Performance period for determining number of shares earned by employee, high end of the range (in years)                         3                          
Maximum percentage of target up to which additional shares may be granted (as a percent)                         200.00%                          
Projected payout (as a percent)                   200.00%                                
Accelerated Share-based Compensation Expense   74                                                
Restricted shares vested and released under performance share unit awards, total intrinsic value $ 72 $ 58 $ 66                                              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period               1,600,000                     3,054,000 173,360 2,311,000